Permisividad por posición | Próximas 5 jornadas desde J27 | Ordenado por facilidad
| # | Equipo | J27 | J28 | J29 | J30 | J31 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
MAN
|
ZAR
|
COV
|
HIO
|
RMA
|
+1,7% | |
| 2 |
GCA
|
BLB
|
GIR
|
COV
|
VBC
|
+1,1% | |
| 3 |
ZAR
|
GIR
|
FCB
|
UNI
|
CAN
|
+1,0% | |
| 4 |
COV
|
HIO
|
JOV
|
GCA
|
BUR
|
+0,1% | |
| 5 |
BAS
|
BRE
|
UNI
|
CAN
|
AND
|
-1,2% | |
| 6 |
HIO
|
BAS
|
GCA
|
BUR
|
COV
|
-1,6% | |
| 7 |
BRE
|
MAN
|
HIO
|
FCB
|
UNI
|
-1,8% | |
| 8 |
FCB
|
UNI
|
BUR
|
BLB
|
BRE
|
-2,6% | |
| 9 |
AND
|
CAN
|
RMA
|
GIR
|
BAS
|
-3,6% | |
| 10 |
BUR
|
JOV
|
BAS
|
RMA
|
HIO
|
-4,4% | |
| 11 |
UNI
|
AND
|
BLB
|
ZAR
|
FCB
|
-4,8% | |
| 12 |
VBC
|
GCA
|
ZAR
|
MUR
|
MAN
|
-6,0% | |
| 13 |
MUR
|
COV
|
CAN
|
MAN
|
JOV
|
-6,2% | |
| 14 |
GIR
|
RMA
|
MAN
|
BAS
|
ZAR
|
-6,8% | |
| 15 |
BLB
|
BUR
|
VBC
|
AND
|
GIR
|
-6,9% | |
| 16 |
RMA
|
MUR
|
AND
|
JOV
|
GCA
|
-10,5% | |
| 17 |
CAN
|
VBC
|
MUR
|
BRE
|
BLB
|
-14,4% | |
| 18 |
JOV
|
FCB
|
BRE
|
VBC
|
MUR
|
-14,4% |
| # | Equipo | J27 | J28 | J29 | J30 | J31 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
ZAR
|
GIR
|
FCB
|
UNI
|
CAN
|
+10,0% | |
| 2 |
HIO
|
BAS
|
GCA
|
BUR
|
COV
|
+6,1% | |
| 3 |
COV
|
HIO
|
JOV
|
GCA
|
BUR
|
+5,0% | |
| 4 |
MAN
|
ZAR
|
COV
|
HIO
|
RMA
|
+3,1% | |
| 5 |
FCB
|
UNI
|
BUR
|
BLB
|
BRE
|
+2,2% | |
| 6 |
BRE
|
MAN
|
HIO
|
FCB
|
UNI
|
+2,2% | |
| 7 |
GIR
|
RMA
|
MAN
|
BAS
|
ZAR
|
+0,1% | |
| 8 |
BUR
|
JOV
|
BAS
|
RMA
|
HIO
|
-3,6% | |
| 9 |
GCA
|
BLB
|
GIR
|
COV
|
VBC
|
-4,9% | |
| 10 |
AND
|
CAN
|
RMA
|
GIR
|
BAS
|
-5,6% | |
| 11 |
BAS
|
BRE
|
UNI
|
CAN
|
AND
|
-7,3% | |
| 12 |
BLB
|
BUR
|
VBC
|
AND
|
GIR
|
-8,5% | |
| 13 |
UNI
|
AND
|
BLB
|
ZAR
|
FCB
|
-8,6% | |
| 14 |
RMA
|
MUR
|
AND
|
JOV
|
GCA
|
-9,4% | |
| 15 |
MUR
|
COV
|
CAN
|
MAN
|
JOV
|
-9,5% | |
| 16 |
VBC
|
GCA
|
ZAR
|
MUR
|
MAN
|
-10,6% | |
| 17 |
JOV
|
FCB
|
BRE
|
VBC
|
MUR
|
-14,0% | |
| 18 |
CAN
|
VBC
|
MUR
|
BRE
|
BLB
|
-24,3% |
| # | Equipo | J27 | J28 | J29 | J30 | J31 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
GCA
|
BLB
|
GIR
|
COV
|
VBC
|
+4,3% | |
| 2 |
ZAR
|
GIR
|
FCB
|
UNI
|
CAN
|
+2,0% | |
| 3 |
BAS
|
BRE
|
UNI
|
CAN
|
AND
|
-0,6% | |
| 4 |
AND
|
CAN
|
RMA
|
GIR
|
BAS
|
-1,3% | |
| 5 |
MAN
|
ZAR
|
COV
|
HIO
|
RMA
|
-1,4% | |
| 6 |
VBC
|
GCA
|
ZAR
|
MUR
|
MAN
|
-3,0% | |
| 7 |
COV
|
HIO
|
JOV
|
GCA
|
BUR
|
-3,0% | |
| 8 |
BLB
|
BUR
|
VBC
|
AND
|
GIR
|
-4,8% | |
| 9 |
BRE
|
MAN
|
HIO
|
FCB
|
UNI
|
-5,4% | |
| 10 |
FCB
|
UNI
|
BUR
|
BLB
|
BRE
|
-5,7% | |
| 11 |
MUR
|
COV
|
CAN
|
MAN
|
JOV
|
-6,0% | |
| 12 |
HIO
|
BAS
|
GCA
|
BUR
|
COV
|
-6,6% | |
| 13 |
GIR
|
RMA
|
MAN
|
BAS
|
ZAR
|
-6,6% | |
| 14 |
CAN
|
VBC
|
MUR
|
BRE
|
BLB
|
-8,4% | |
| 15 |
UNI
|
AND
|
BLB
|
ZAR
|
FCB
|
-8,5% | |
| 16 |
BUR
|
JOV
|
BAS
|
RMA
|
HIO
|
-9,7% | |
| 17 |
JOV
|
FCB
|
BRE
|
VBC
|
MUR
|
-15,8% | |
| 18 |
RMA
|
MUR
|
AND
|
JOV
|
GCA
|
-17,1% |
| # | Equipo | J27 | J28 | J29 | J30 | J31 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
BAS
|
BRE
|
UNI
|
CAN
|
AND
|
+4,2% | |
| 2 |
GCA
|
BLB
|
GIR
|
COV
|
VBC
|
+3,9% | |
| 3 |
MAN
|
ZAR
|
COV
|
HIO
|
RMA
|
+3,2% | |
| 4 |
UNI
|
AND
|
BLB
|
ZAR
|
FCB
|
+2,6% | |
| 5 |
BUR
|
JOV
|
BAS
|
RMA
|
HIO
|
+0,1% | |
| 6 |
COV
|
HIO
|
JOV
|
GCA
|
BUR
|
-1,6% | |
| 7 |
BRE
|
MAN
|
HIO
|
FCB
|
UNI
|
-2,1% | |
| 8 |
MUR
|
COV
|
CAN
|
MAN
|
JOV
|
-3,1% | |
| 9 |
AND
|
CAN
|
RMA
|
GIR
|
BAS
|
-3,8% | |
| 10 |
HIO
|
BAS
|
GCA
|
BUR
|
COV
|
-4,3% | |
| 11 |
FCB
|
UNI
|
BUR
|
BLB
|
BRE
|
-4,4% | |
| 12 |
VBC
|
GCA
|
ZAR
|
MUR
|
MAN
|
-4,5% | |
| 13 |
RMA
|
MUR
|
AND
|
JOV
|
GCA
|
-4,9% | |
| 14 |
BLB
|
BUR
|
VBC
|
AND
|
GIR
|
-7,3% | |
| 15 |
ZAR
|
GIR
|
FCB
|
UNI
|
CAN
|
-8,8% | |
| 16 |
CAN
|
VBC
|
MUR
|
BRE
|
BLB
|
-10,5% | |
| 17 |
JOV
|
FCB
|
BRE
|
VBC
|
MUR
|
-13,4% | |
| 18 |
GIR
|
RMA
|
MAN
|
BAS
|
ZAR
|
-14,0% |

















